Between the years 2011 and 2015 the medical research Journal Oncotarget holds an impressive Research Gate impact rating. It starts somewhere in the range of 4 points and jumps up to a high 5 number and tails off at a mid-range 3 in the end. This rating is based on the number of citations that are used in the medical journal publication about different clinical studies conducted on various subjects. Follow Oncotarget on Twitter.
If it feels as if this rating functions like something of a statistic, which doesn’t make it good or bad in anyway, that’s because it is somewhat. However, any information of this nature requires analyzation and a bit of expounding if it is to be of any use. Of course, the best way to gauge this value is through a grassroots look at the data collected and the research conducted throughout the different studies and subjects that the medical field attempts to learn from.
A good example of this is a breakthrough study about PTC (Papillary Thyroid Carcinoma) and the different genetic mutations that cause it. This study also closely looks at the different combinations of medicines that are effective and its treatment. The long and short is that there are drug combinations available that actually kill the cancer cells and stop them from reproducing. The medication’s ability certainty feels like a breakthrough because this this type of cancer is known for building a genetic drug resistance to the pinpoint medications used against it. Follow Oncotarget on Linkedin.
The study also found another genetic anomaly in this cancer type of cancer cell that may lead to finding key to its drug resistance capabilities. Such findings are sure to lower the number of cases where doctors have to inform patients that the cancer which looked as if it were in remission has made a come back. The rising number of breakthrough research efforts in studies like this may be why citations are down in the Oncotarget publication. The simple fact is researchers may be too busy making headway, which would cut back on the use of reverse engineering and citation. But, no matter what is happening in the medical field this journal is peer-reviewed and printed bi-weekly which still makes it a excellent source of information and authoritative reference.
— Oncotarget (@OncotargetJrnl) December 5, 2017